CACI Form 4: 338 RSUs awarded to Director Stanton Sloane
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CACI International Inc. (CACI) director Stanton D. Sloane reported an equity award on a Form 4. On October 16, 2025, he acquired 338 Restricted Stock Units (RSUs), listed as derivative securities tied to CACI common stock.
The RSUs vest in four installments during 2026: 84 shares on January 14, 84 shares on April 14, 85 shares on July 13, and 85 shares on October 11. Following this grant, the filing shows 338 derivative securities beneficially owned, held directly.
This is a routine director compensation grant disclosed under Section 16, with a defined vesting schedule that spreads delivery over the 2026 calendar year.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Sloane Stanton D
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 338 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 338 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did CACI (CACI) disclose in this Form 4?
A director, Stanton D. Sloane, reported receiving 338 RSUs on October 16, 2025.
How do the 338 CACI RSUs vest for Stanton D. Sloane?
They vest in 2026: 84 on Jan 14, 84 on Apr 14, 85 on Jul 13, and 85 on Oct 11.
What type of security was reported in the CACI Form 4?
Restricted Stock Units (RSUs) listed as derivative securities linked to CACI common stock.
How many derivative securities are shown as beneficially owned after the transaction?
The filing shows 338 derivative securities beneficially owned, held directly.
Who is the reporting person in this CACI Form 4?
Director Stanton D. Sloane.